Wishlist (0)
Welcome visitor Login or Register.
My Cart    0 $0.00
Your shopping cart is empty!
Ki16425

Ki16425

0 reviews Write a review
Product Code: 3409
Availability: In Stock
$209.00
-+

Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 μM, 6.5 μM and 0.93 μM, respectively, shows no activity at LPA4, LPA5, LPA6.

Chemical Name 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl)-3-methylisoxazol-5-yl)benzylthio)propanoic acid

Inhibitors GPCR & G Protein LPA Receptor Ki16425 355025-24-0
Biological Activity:
Biological Activity Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 μM, 6.5 μM and 0.93 μM, respectively, shows no activity at LPA4, LPA5, LPA6.
Technical Data:
M.W. 474.96
Formula: <p>C<sub>23</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>5</sub>S</p>
Solubility: DMSO
Purity: 98%
Storage: -20℃
CAS No: 355025-24-0
References:
References Ohta H, et al, Mol Pharmacol, 2003, 64(4), 994-1005. Moughal NA, et al. J Neurochem, 2006, 98(6), 1920-1929. Nochi H, et al. J Immunol, 2008, 181(7), 5111-5119. Ma L, et al. J Neurochem, 2009, 109(2), 603-610.

Write a review

Note: HTML is not translated!
    Bad           Good
Continue

About HDH PHARMA

At HDH Pharma, we are committed to offering our clients the highest quality research services with the most convenient and effective communications from both US and Indian operations. Clients in the Americas and Europe can pick up the phone and speak directly with our scientists in the US. Clients in Asia can receive the same rapid response from our scientists in India. HDH’s hybrid operation is designed with our client’s operational needs in mind.


Information

Extras

My Account

Powered By Nsoft Solutions
HDH PHARMA © 2024